Multiple Sclerosis Clinical Trial
— STEMOfficial title:
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | March 31, 2025 |
Est. primary completion date | February 15, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 59 Years |
Eligibility | Inclusion Criteria: - Diagnosis of Multiple Sclerosis - Ability to read and speak English fluently - Difficulties with learning and memory skills Exclusion Criteria: - Prior diagnosis of stroke or other neurological injury/disease - Flare up of symptoms within a month of study participation - History of significant psychiatric illness (e.g., bipolar disorder, schizophrenia, psychosis) or current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II - Current significant alcohol or substance abuse - Taking exclusionary medication (study team will review medications) For Optional MRI: - Pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids [cochlear implants]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments. - Dental implants - Left-handed |
Country | Name | City | State |
---|---|---|---|
United States | Kessler Foundation | East Hanover | New Jersey |
United States | Kessler Rehabilitation Center | Marlton | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Kessler Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in scores on self-report measure of everyday cognition (subjective) | Perceived Deficits Questionnaire | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Primary | Changes in scores on self-report measure of everyday cognition (objective) | Ecologic Memory Simulations | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in auditory processing speed | Paced Auditory Serial Edition Test | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in information processing speed | Symbol Digit Modalities Test | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in episodic verbal memory and learning | California Verbal Learning Test - 2nd Edition | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in visuospatial memory | Brief Visuospatial Memory Test - Revised | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in ability in spontaneous production of words | Controlled Oral Word Association Test | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in visual perception | Benton Judgment of Line Orientation | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) | |
Secondary | Changes in executive function | Delis-Kaplan Executive Function System - Sorting | Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|